<p>Gamco Investors INC. ET AL 在最近向美國證券交易委員會（SEC）披露的信息中表示，在第四季度減少了對 CVS Health Corporation (NYSE:CVS - 免費報告) 的持股比例，降幅為 11.6%。該機構投資者在此期間出售了 14,768 股後，持有 112,713 股該藥房運營商的股票。根據其最近向 SEC 提交的文件，Gamco Investors INC. ET AL 在 CVS Health 的持股價值為 8,945,000 美元。</p>
<ul>
<li>3 只醫療保健股票將受益於這項重大法案</li>
</ul>
<p>其他幾家機構投資者和對沖基金也買賣了該股票的股份。國家養老金服務在第三季度將其在 CVS Health 的持股比例提高了 3.1%。國家養老金服務目前持有 3,999,622 股該藥房運營商的股票，價值 301,532,000 美元，此前在上個季度又購買了 119,189 股。Kingsview Wealth Management LLC 在第三季度將其在 CVS Health 的持股比例提高了 316.2%。Kingsview Wealth Management LLC 目前持有 104,432 股該藥房運營商的股票，價值 7,873,000 美元，此前在上個季度又購買了 79,340 股。AE Wealth Management LLC 在第三季度將其在 CVS Health 的持股比例提高了 6.2%。AE Wealth Management LLC 目前持有 257,204 股該藥房運營商的股票，價值 19,391,000 美元，此前在上個季度又購買了 14,983 股。未來資產全球投資有限公司在第三季度將其在 CVS Health 的持股比例提高了 11.2%。未來資產全球投資有限公司目前持有 225,116 股該藥房運營商的股票，價值 16,971,000 美元，此前在上個季度又購買了 22,653 股。最後，財富提升顧問服務有限公司在第三季度將其在 CVS Health 的持股比例提高了 186.6%。財富提升顧問服務有限公司目前持有 396,368 股該藥房運營商的股票，價值 30,568,000 美元，此前在上個季度又購買了 258,050 股。機構投資者持有該公司 80.66% 的股票。</p>
<h2>分析師評級變動</h2>
<p>多位股票分析師對 CVS 股票發表了看法。華爾街禪在 5 月 9 日的研究報告中將 CVS Health 的評級從 “持有” 上調至 “買入”。摩根大通在 5 月 12 日的研究報告中將 CVS Health 的目標價從 101.00 美元上調至 111.00 美元，並給予該股票 “超配” 評級。羅伯特·W·貝爾德在 4 月 15 日的研究報告中將 CVS Health 的目標價從 92.00 美元上調至 94.00 美元，並給予該股票 “跑贏大盤” 評級。韋斯評級在 5 月 8 日的研究報告中重申了對 CVS Health 股票的 “持有（c）” 評級。最後，巴克萊在 5 月 7 日的研究報告中將 CVS Health 的目標價從 93.00 美元上調至 101.00 美元，並給予該公司 “超配” 評級。22 位股票研究分析師對該股票給予了買入評級，4 位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，平均目標價為 98.08 美元。</p>
<ul>
<li>這隻 ETF 證明醫療保健反彈是真實的</li>
</ul>
<p><strong>查看我們關於 CVS 的最新報告</strong></p>
<h2>CVS Health 的內部交易</h2>
<p>在相關消息中，執行副總裁 Tilak Mandadi 於 5 月 8 日星期五出售了 69,551 股該股票。該股票的平均售價為 89.58 美元，總交易額為 6,230,378.58 美元。出售後，該執行副總裁持有 10,133 股公司股票，價值 907,714.14 美元。這代表其持股比例減少了 87.28%。該交易已在向 SEC 提交的文件中披露，相關信息可通過 SEC 網站獲取。0.85% 的股票由公司內部人士持有。</p>
<h2>CVS Health 的價格表現</h2>
<ul>
<li>CVS Health 隨着收入增長而上漲，股息保持強勁</li>
</ul>
<p>CVS Health 股票在星期三開盤價為 94.18 美元。CVS Health Corporation 的 12 個月低點為 58.50 美元，12 個月高點為 98.43 美元。該股票的 50 日移動平均線為 79.39 美元，200 日移動平均線為 78.76 美元。該公司的流動比率為 0.87，速動比率為 0.66，債務與股本比率為 0.78。該公司的市值為 1201.6 億美元，市盈率為 41.49，PEG 比率為 0.94，貝塔值為 0.60。</p>
<p>CVS Health (NYSE:CVS - 獲取免費報告) 最近在 5 月 6 日星期三發佈了其財報。該藥房運營商報告本季度每股收益為 2.57 美元，超出市場共識預期的 2.21 美元，超出幅度為 0.36 美元。CVS Health 的股本回報率為 11.88%，淨利潤率為 0.72%。該公司本季度的收入為 1004.3 億美元，而市場共識預期為 949.9 億美元。在去年同期，該公司每股收益為 2.25 美元。該公司本季度的收入同比增長 6.2%。CVS Health 已將其 2026 財年的每股收益指導設定為 7.300-7.500。股票研究分析師預計 CVS Health Corporation 本年度將發佈 7.44 美元的每股收益。</p>
<h2>CVS Health 宣佈分紅</h2>
<p>該公司最近還宣佈了季度分紅，已於 5 月 4 日星期一支付。4 月 23 日的登記投資者獲得了每股 0.665 美元的分紅。該分紅的除息日期為 4 月 23 日。這相當於每年 2.66 美元的分紅，收益率為 2.8%。CVS Health 的分紅支付比率目前為 117.18%。</p>
<h2>關於 CVS Health 的熱門頭條</h2>
<p>以下是本週影響 CVS Health 的主要新聞故事：</p>
<ul>
<li>積極情緒：CVS Health 和 WGU 推出了一個在線預藥學學位項目，旨在為全國未來的藥劑師建立人才儲備，這可能有助於解決勞動力短缺問題，並支持 CVS 的零售藥房運營。CVS Health(R) 和 WGU 為全國未來藥劑師推出在線預藥學學位項目</li>
<li>積極情緒：CVS 還支持 EnsembleIQ 的活動，倡導零售藥房作為填補醫療空白的一種方式，進一步鞏固了 CVS 在社區藥房和醫療服務獲取中的角色。EnsembleIQ 的 DSN，作為社區藥房領域的可信來源，發起支持零售藥房填補醫療空白的活動</li>
<li>積極情緒：CVS Health 發佈的一項研究顯示，許多醫療保險成員在數字健康素養方面存在困難，這支持了公司在數字工具和成員參與方面的投資。CVS Health 研究揭示了醫療保險成員對更高數字健康素養的需求</li>
</ul>
<h2>CVS Health 公司簡介</h2>
<p>（免費報告）</p>
<p>CVS Health Corporation 是一家多元化的醫療保健公司，運營着一個大型零售藥房網絡、藥房福利管理服務和醫療解決方案。公司總部位於羅德島州的伍恩索克特，其根源可以追溯到 20 世紀 60 年代初，已發展成為一個綜合性處方藥、非處方產品、臨牀服務和健康保險產品的提供者。其運營模式結合了零售藥房和店內診所以及更廣泛的藥房和健康計劃能力。</p>
<p>主要業務活動包括 CVS 藥房零售運營、MinuteClinic 診所和提供擴展臨牀服務的 HealthHUB 位置。</p>
<h2>推薦故事</h2>
<ul>
<li>五隻我們認為比 CVS Health 更好的股票</li>
<li>HIVE 利用力量進行 AI 轉型</li>
<li>深入探討 NVIDIA 最新的投資組合動態</li>
<li>Brady Corp 進行大規模 AI 驅動的突破</li>
<li>為什麼家得寶的拋售可能成為一個巨大機會</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
<p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，而 CVS Health 並不在名單上。</p>
<p>雖然 CVS Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

西維斯

<p>Gamco Investors INC. 等在第四季度減少了對 CVS Health Corporation 的持股比例 11.6%，出售了 14,768 股。出售後，其持有 112,713 股，估值約為 895 萬美元。其他機構投資者也調整了在 CVS Health 的持倉，顯著增加了持股。CVS Health 的股票共識評級為 “適度買入”，平均目標價為 98.08 美元</p>

<p>Gamco Investors INC. ET AL lessened its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 11.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 112,713 shares of the pharmacy operator's stock after selling 14,768 shares during the period. Gamco Investors INC. ET AL's holdings in CVS Health were worth $8,945,000 as of its most recent filing with the SEC.</p>
<div class="lb-trans"><p>Gamco Investors INC. ET AL 在最近向美國證券交易委員會（SEC）披露的信息中表示，在第四季度減少了對 CVS Health Corporation (NYSE:CVS - 免費報告) 的持股比例，降幅為 11.6%。該機構投資者在此期間出售了 14,768 股後，持有 112,713 股該藥房運營商的股票。根據其最近向 SEC 提交的文件，Gamco Investors INC. ET AL 在 CVS Health 的持股價值為 8,945,000 美元。</p>
</div><ul>
<li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只醫療保健股票將受益於這項重大法案</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also bought and sold shares of the stock. National Pension Service increased its position in CVS Health by 3.1% during the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator's stock worth $301,532,000 after buying an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC increased its position in CVS Health by 316.2% during the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator's stock worth $7,873,000 after buying an additional 79,340 shares during the last quarter. AE Wealth Management LLC increased its position in CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator's stock worth $19,391,000 after buying an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its position in CVS Health by 11.2% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator's stock worth $16,971,000 after buying an additional 22,653 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in CVS Health by 186.6% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 396,368 shares of the pharmacy operator's stock worth $30,568,000 after buying an additional 258,050 shares during the last quarter. Institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金也買賣了該股票的股份。國家養老金服務在第三季度將其在 CVS Health 的持股比例提高了 3.1%。國家養老金服務目前持有 3,999,622 股該藥房運營商的股票，價值 301,532,000 美元，此前在上個季度又購買了 119,189 股。Kingsview Wealth Management LLC 在第三季度將其在 CVS Health 的持股比例提高了 316.2%。Kingsview Wealth Management LLC 目前持有 104,432 股該藥房運營商的股票，價值 7,873,000 美元，此前在上個季度又購買了 79,340 股。AE Wealth Management LLC 在第三季度將其在 CVS Health 的持股比例提高了 6.2%。AE Wealth Management LLC 目前持有 257,204 股該藥房運營商的股票，價值 19,391,000 美元，此前在上個季度又購買了 14,983 股。未來資產全球投資有限公司在第三季度將其在 CVS Health 的持股比例提高了 11.2%。未來資產全球投資有限公司目前持有 225,116 股該藥房運營商的股票，價值 16,971,000 美元，此前在上個季度又購買了 22,653 股。最後，財富提升顧問服務有限公司在第三季度將其在 CVS Health 的持股比例提高了 186.6%。財富提升顧問服務有限公司目前持有 396,368 股該藥房運營商的股票，價值 30,568,000 美元，此前在上個季度又購買了 258,050 股。機構投資者持有該公司 80.66% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>A number of equities analysts have weighed in on CVS shares. Wall Street Zen raised CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, May 9th. JPMorgan Chase &amp; Co. boosted their price target on CVS Health from $101.00 to $111.00 and gave the stock an &#34;overweight&#34; rating in a research report on Tuesday, May 12th. Robert W. Baird boosted their price target on CVS Health from $92.00 to $94.00 and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, April 15th. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of CVS Health in a research report on Friday, May 8th. Finally, Barclays upped their target price on CVS Health from $93.00 to $101.00 and gave the company an &#34;overweight&#34; rating in a research report on Thursday, May 7th. Twenty-two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $98.08.</p>
<div class="lb-trans"><p>多位股票分析師對 CVS 股票發表了看法。華爾街禪在 5 月 9 日的研究報告中將 CVS Health 的評級從 “持有” 上調至 “買入”。摩根大通在 5 月 12 日的研究報告中將 CVS Health 的目標價從 101.00 美元上調至 111.00 美元，並給予該股票 “超配” 評級。羅伯特·W·貝爾德在 4 月 15 日的研究報告中將 CVS Health 的目標價從 92.00 美元上調至 94.00 美元，並給予該股票 “跑贏大盤” 評級。韋斯評級在 5 月 8 日的研究報告中重申了對 CVS Health 股票的 “持有（c）” 評級。最後，巴克萊在 5 月 7 日的研究報告中將 CVS Health 的目標價從 93.00 美元上調至 101.00 美元，並給予該公司 “超配” 評級。22 位股票研究分析師對該股票給予了買入評級，4 位分析師給予了持有評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “適度買入”，平均目標價為 98.08 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>這隻 ETF 證明醫療保健反彈是真實的</li>
</ul>
</div><p><strong>Check Out Our Latest Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CVS 的最新報告</strong></p>
</div><h2>Insider Transactions at CVS Health</h2>
<div class="lb-trans"><h2>CVS Health 的內部交易</h2>
</div><p>In related news, EVP Tilak Mandadi sold 69,551 shares of the stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president owned 10,133 shares of the company's stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.85% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相關消息中，執行副總裁 Tilak Mandadi 於 5 月 8 日星期五出售了 69,551 股該股票。該股票的平均售價為 89.58 美元，總交易額為 6,230,378.58 美元。出售後，該執行副總裁持有 10,133 股公司股票，價值 907,714.14 美元。這代表其持股比例減少了 87.28%。該交易已在向 SEC 提交的文件中披露，相關信息可通過 SEC 網站獲取。0.85% 的股票由公司內部人士持有。</p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 的價格表現</h2>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 隨着收入增長而上漲，股息保持強勁</li>
</ul>
</div><p>CVS Health stock opened at $94.18 on Wednesday. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $98.43. The stock's 50 day moving average is $79.39 and its 200-day moving average is $78.76. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. The company has a market capitalization of $120.16 billion, a price-to-earnings ratio of 41.49, a PEG ratio of 0.94 and a beta of 0.60.</p>
<div class="lb-trans"><p>CVS Health 股票在星期三開盤價為 94.18 美元。CVS Health Corporation 的 12 個月低點為 58.50 美元，12 個月高點為 98.43 美元。該股票的 50 日移動平均線為 79.39 美元，200 日移動平均線為 78.76 美元。該公司的流動比率為 0.87，速動比率為 0.66，債務與股本比率為 0.78。該公司的市值為 1201.6 億美元，市盈率為 41.49，PEG 比率為 0.94，貝塔值為 0.60。</p>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. During the same quarter in the prior year, the business earned $2.25 earnings per share. The firm's revenue for the quarter was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts expect that CVS Health Corporation will post 7.44 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 獲取免費報告) 最近在 5 月 6 日星期三發佈了其財報。該藥房運營商報告本季度每股收益為 2.57 美元，超出市場共識預期的 2.21 美元，超出幅度為 0.36 美元。CVS Health 的股本回報率為 11.88%，淨利潤率為 0.72%。該公司本季度的收入為 1004.3 億美元，而市場共識預期為 949.9 億美元。在去年同期，該公司每股收益為 2.25 美元。該公司本季度的收入同比增長 6.2%。CVS Health 已將其 2026 財年的每股收益指導設定為 7.300-7.500。股票研究分析師預計 CVS Health Corporation 本年度將發佈 7.44 美元的每股收益。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣佈分紅</h2>
</div><p>The business also recently declared a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health's dividend payout ratio is currently 117.18%.</p>
<div class="lb-trans"><p>該公司最近還宣佈了季度分紅，已於 5 月 4 日星期一支付。4 月 23 日的登記投資者獲得了每股 0.665 美元的分紅。該分紅的除息日期為 4 月 23 日。這相當於每年 2.66 美元的分紅，收益率為 2.8%。CVS Health 的分紅支付比率目前為 117.18%。</p>
</div><h2>Trending Headlines about CVS Health</h2>
<div class="lb-trans"><h2>關於 CVS Health 的熱門頭條</h2>
</div><p>Here are the key news stories impacting CVS Health this week:</p>
<div class="lb-trans"><p>以下是本週影響 CVS Health 的主要新聞故事：</p>
</div><ul>
<li>Positive Sentiment: CVS Health and WGU launched an online pre-pharmacy degree program aimed at building a pipeline of future pharmacists nationwide, which could help address labor shortages and support CVS’s retail pharmacy operations. CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide</li>
<li>Positive Sentiment: CVS also backed EnsembleIQ’s campaign supporting retail pharmacy as a way to help fill healthcare gaps, reinforcing CVS’s role in community pharmacy and care access. EnsembleIQ’s DSN, a Trusted Source in the Community Pharmacy Space, Launches Campaign in Support of Retail Pharmacy Filling Health Care Gaps</li>
<li>Positive Sentiment: CVS Health published a study showing many Medicare members struggle with digital health literacy, which supports the company’s push to invest in digital tools and member engagement. CVS Health study reveals a need for greater digital health literacy for Medicare members</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：CVS Health 和 WGU 推出了一個在線預藥學學位項目，旨在為全國未來的藥劑師建立人才儲備，這可能有助於解決勞動力短缺問題，並支持 CVS 的零售藥房運營。CVS Health(R) 和 WGU 為全國未來藥劑師推出在線預藥學學位項目</li>
<li>積極情緒：CVS 還支持 EnsembleIQ 的活動，倡導零售藥房作為填補醫療空白的一種方式，進一步鞏固了 CVS 在社區藥房和醫療服務獲取中的角色。EnsembleIQ 的 DSN，作為社區藥房領域的可信來源，發起支持零售藥房填補醫療空白的活動</li>
<li>積極情緒：CVS Health 發佈的一項研究顯示，許多醫療保險成員在數字健康素養方面存在困難，這支持了公司在數字工具和成員參與方面的投資。CVS Health 研究揭示了醫療保險成員對更高數字健康素養的需求</li>
</ul>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的醫療保健公司，運營着一個大型零售藥房網絡、藥房福利管理服務和醫療解決方案。公司總部位於羅德島州的伍恩索克特，其根源可以追溯到 20 世紀 60 年代初，已發展成為一個綜合性處方藥、非處方產品、臨牀服務和健康保險產品的提供者。其運營模式結合了零售藥房和店內診所以及更廣泛的藥房和健康計劃能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要業務活動包括 CVS 藥房零售運營、MinuteClinic 診所和提供擴展臨牀服務的 HealthHUB 位置。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>HIVE Weaponizes Power for an AI Pivot</li>
<li>A Deep Dive Into NVIDIA’s Latest Portfolio Moves</li>
<li>Brady Corp Wires Up a Massive AI-Powered Breakout</li>
<li>Why Home Depot’s Sell-Off Could Become a Huge Opportunity</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們認為比 CVS Health 更好的股票</li>
<li>HIVE 利用力量進行 AI 轉型</li>
<li>深入探討 NVIDIA 最新的投資組合動態</li>
<li>Brady Corp 進行大規模 AI 驅動的突破</li>
<li>為什麼家得寶的拋售可能成為一個巨大機會</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，而 CVS Health 並不在名單上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CVS Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Gamco Investors INC. ET AL Sells 14,768 Shares of CVS Health Corporation $CVS

Market Beat

GAMCO Investors, Inc.

摩根大通

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Gamco Investors INC. ET AL 出售了 14,768 股西維斯健康公司的股票 $CVS